UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

Nature communications, 2021-09, Vol.12 (1), p.5668-5668, Article 5668

2021

Link zum Volltext

Verfügbarkeit prüfen

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation

Haematologica (Roma), 2021-02, Vol.106 (2), p.585-588

2021

Link zum Volltext

Verfügbarkeit prüfen

V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma

Cancers, 2021-05, Vol.13 (9), p.2219

2021

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients

Cancers, 2022-09, Vol.14 (17), p.4298

2022

Link zum Volltext

Verfügbarkeit prüfen

361 T cell receptor specific for tumor-restricted Ropporin-1 to treat triple negative breast cancer

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A410-A410

2023

Link zum Volltext

Verfügbarkeit prüfen

Innovative platforms for development of TCR-T cell therapies against novel tumor targets: Triple negative breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14536-e14536

2023

Link zum Volltext

Verfügbarkeit prüfen

Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy

Methods in molecular biology (Clifton, N.J.), 2022, Vol.2453, p.209

2022

Link zum Volltext

Verfügbarkeit prüfen

MO26-2 Intra-tumoral clusters between CD20+ B cells and BCL6+ CD4+ T cells are prognostic in early oral cancers

Annals of oncology, 2022-07, Vol.33, p.S498

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes

Journal for immunotherapy of cancer, 2020-08, Vol.8 (2), p.e000271

2020

Link zum Volltext

Verfügbarkeit prüfen

CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation

Blood, 2016-10, Vol.128 (17), p.2165-2174

2016

Link zum Volltext

Verfügbarkeit prüfen

Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8 + T cells

Clinical cancer research, 2022-01, Vol.28 (1), p.215-226

2022

Link zum Volltext

Verfügbarkeit prüfen

Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients

Journal of neuro-oncology, 2019-08, Vol.144 (1), p.79-87

2019

Link zum Volltext

Verfügbarkeit prüfen

Recurrence of Melanoma Following T Cell Treatment: Continued Antigen Expression in a Tumor That Evades T Cell Recruitment

Molecular therapy, 2015-02, Vol.23 (2), p.396-406

2015

Link zum Volltext

Verfügbarkeit prüfen

Early CD4+ T-Cell Effector Alloreactivity Towards Multiple Mismatched HLA Class II Alleles Is Associated with Graft Predominance after Double Umbilical Cord Blood Transplantation (dUCBT)

Blood, 2015-12, Vol.126 (23), p.387-387

2015

Link zum Volltext

Verfügbarkeit prüfen

Lack of B and T cell reactivity towards IDH1 R132H in blood and tumor tissue from LGG patients

Journal of neuro-oncology, 2019-08, Vol.144 (1), p.79

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

CD4+ T-cell alloreactivity after haploidentical hematopoietic stem cell transplantation

V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma

Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients

361 T cell receptor specific for tumor-restricted Ropporin-1 to treat triple negative breast cancer

Double Umbilical Cord Blood Transplantation in High‐Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance

Innovative platforms for development of TCR-T cell therapies against novel tumor targets: Triple negative breast cancer

Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy

MO26-2 Intra-tumoral clusters between CD20+ B cells and BCL6+ CD4+ T cells are prognostic in early oral cancers

Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes

CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation

Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8 + T cells

Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients

Recurrence of Melanoma Following T Cell Treatment: Continued Antigen Expression in a Tumor That Evades T Cell Recruitment

Early CD4+ T-Cell Effector Alloreactivity Towards Multiple Mismatched HLA Class II Alleles Is Associated with Graft Predominance after Double Umbilical Cord Blood Transplantation (dUCBT)

Lack of B and T cell reactivity towards IDH1 R132H in blood and tumor tissue from LGG patients

Suchergebnisse filtern